Cyp1b1 mediates periostin regulation of trabecular meshwork development by suppression of oxidative stress

Molecular and Cellular Biology

Volumn 33, Issue 21, 2013, Pages 4225-4240

  Zhao, Yun ^a   Wang, Shoujian ^a   Sorenson, Christine M ^a   Teixeira, Leandro ^b   Dubielzig, Richard R ^b   Peters, Donna M ^a   Conway, Simon J ^c   Jefcoate, Colin R ^a   Sheibani, Nader ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; COLLAGEN; CYTOCHROME P450 1B1; TRANSCRIPTION FACTOR RUNX2;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL ADHESION; CELL PROLIFERATION; CONTROLLED STUDY; GLAUCOMA; INTRAOCULAR PRESSURE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRABECULAR MESHWORK;

MUS;

EID: 84886885095     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.00856-13     Document Type: Article

References (80)

1. Quigley HA, Broman AT. 2006. The number of people with glaucoma worldwide in 2010 and 2020. Br. J. Ophthalmol. 90:262-267.
2. Weinreb RN, Khaw PT. 2004. Primary open-angle glaucoma. Lancet 363:1711-1720.
3. Tamm ER. 2009. The trabecular meshwork outflow pathways: structural and functional aspects. Exp. Eye Res. 88:648-655.
4. Savas U, Bhattacharyya KK, Christou M, Alexander DL, Jefcoate CR. 1994. Mouse cytochrome P-450EF, representative of a new 1B subfamily of cytochrome P-450s. Cloning, sequence determination, and tissue expression. J. Biol. Chem. 269:14905-14911.
5. Sutter TR, Tang YM, Hayes CL, Wo YY, Jabs EW, Li X, Yin H, Cody CW, Greenlee WF. 1994. Complete cDNA sequence of a human dioxininducible mRNA identifies a new gene subfamily of cytochrome P450 that maps to chromosome 2. J. Biol. Chem. 269:13092-13099.
6. Coon MJ. 2005. Cytochrome P450: nature's most versatile biological catalyst. Annu. Rev. Pharmacol. Toxicol. 45:1-25.
7. Jansson I, Stoilov I, Sarfarazi M, Schenkman JB. 2001. Effect of two mutations of human CYP1B1, G61E and R469W, on stability and endogenous steroid substrate metabolism. Pharmacogenetics 11:793-801.
8. Chambers D, Wilson L, Maden M, Lumsden A. 2007. RALDHindependent generation of retinoic acid during vertebrate embryogenesis by CYP1B1. Development 134:1369-1383.
9. Choudhary D, Jansson I, Stoilov I, Sarfarazi M, Schenkman JB. 2004. Metabolism of retinoids and arachidonic acid by human and mouse cytochrome P450 1b1. Drug Metab. Dispos. 32:840-847.
10. Boutin JA, Audinot V, Ferry G, Delagrange P. 2005. Molecular tools to study melatonin pathways and actions. Trends Pharmacol. Sci. 26:412-419.
11. Ma X, Idle JR, Krausz KW, Gonzalez FJ. 2005. Metabolism of melatonin by human cytochromes p450. Drug Metab. Dispos. 33:489-494.
12. Young IM, Leone RM, Francis P, Stovell P, Silman RE. 1985. Melatonin is metabolized to N-acetyl serotonin and 6-hydroxymelatonin in man. J. Clin. Endocrinol. Metab. 60:114-119.
13. Tang Y, Scheef EA, Wang S, Sorenson CM, Marcus CB, Jefcoate CR, Sheibani N. 2009. CYP1B1 expression promotes the proangiogenic phenotype of endothelium through decreased intracellular oxidative stress and thrombospondin-2 expression. Blood 113:744-754.
14. Choudhary D, Jansson I, Rezaul K, Han DK, Sarfarazi M, Schenkman JB. 2007. Cyp1b1 protein in the mouse eye during development: an immunohistochemical study. Drug Metab. Dispos. 35:987-994.
15. Hakkola J, Pasanen M, Pelkonen O, Hukkanen J, Evisalmi S, Anttila S, Rane A, Mantyla M, Purkunen R, Saarikoski S, Tooming M, Raunio H. 1997. Expression of CYP1B1 in human adult and fetal tissues and differential inducibility of CYP1B1 and CYP1A1 by Ah receptor ligands in human placenta and cultured cells. Carcinogenesis 18:391-397.
16. Stoilov I, Rezaie T, Jansson I, Schenkman JB, Sarfarazi M. 2004. Expression of cytochrome P4501b1 (Cyp1b1) during early murine development. Mol. Vis. 10:629-636.
17. Panicker SG, Reddy AB, Mandal AK, Ahmed N, Nagarajaram HA, Hasnain SE, Balasubramanian D. 2002. Identification of novel mutations causing familial primary congenital glaucoma in Indian pedigrees. Invest. Ophthalmol. Vis. Sci. 43:1358-1366.
18. Soley GC, Bosse KA, Flikier D, Flikier P, Azofeifa J, Mardin CY, Reis A, Michels-Rautenstrauss KG, Rautenstrauss BW. 2003. Primary congenital glaucoma: a novel single-nucleotide deletion and varying phenotypic expression for the 1,546-1,555dup mutation in the GLC3A (CYP1B1) gene in 2 families of different ethnic origin. J. Glaucoma 12:27-30.
19. Vincent AL, Billingsley G, Buys Y, Levin AV, Priston M, Trope G, Williams-Lyn D, Heon E. 2002. Digenic inheritance of early-onset glaucoma: CYP1B1, a potential modifier gene. Am. J. Hum. Genet. 70:448-460.
20. Stoilov I, Akarsu AN, Sarfarazi M. 1997. Identification of three different truncating mutations in cytochrome P4501B1 (CYP1B1) as the principal cause of primary congenital glaucoma (buphthalmos) in families linked to the GLC3A locus on chromosome 2p21. Hum. Mol. Genet. 6:641-647.
21. Libby RT, Smith RS, Savinova OV, Zabaleta A, Martin JE, Gonzalez FJ, Zhao et al. John SW. 2003. Modification of ocular defects in mouse developmental glaucoma models by tyrosinase. Science 299:1578-1581.
22. Gabelt BT, Kaufman PL. 2005. Changes in aqueous humor dynamics with age and glaucoma. Prog. Retin. Eye Res. 24:612-637.
23. Aihara M, Lindsey JD, Weinreb RN. 2003. Ocular hypertension in mice with a targeted type I collagen mutation. Invest. Ophthalmol. Vis. Sci. 44(4):1581-1585.
24. Kupfer C, Kaiser-Kupfer MI. 1979. Observations on the development of the anterior chamber angle with reference to the pathogenesis of congenital glaucomas. Am. J. Ophthalmol. 88:424-426.
25. Borras T, Comes N. 2009. Evidence for a calcification process in the trabecular meshwork. Exp. Eye Res. 88:738-746.
26. Horiuchi K, Amizuka N, Takeshita S, Takamatsu H, Katsuura M, Ozawa H, Toyama Y, Bonewald LF, Kudo A. 1999. Identification and characterization of a novel protein, periostin, with restricted expression to periosteum and periodontal ligament and increased expression by transforming growth factor beta. J. Bone Miner. Res. 14:1239-1249.
27. Norris RA, Damon B, Mironov V, Kasyanov V, Ramamurthi A, Moreno-Rodriguez R, Trusk T, Potts JD, Goodwin RL, Davis J, Hoffman S, Wen X, Sugi Y, Kern CB, Mjaatvedt CH, Turner DK, Oka T, Conway SJ, Molkentin JD, Forgacs G, Markwald RR. 2007. Periostin regulates collagen fibrillogenesis and the biomechanical properties of connective tissues. J. Cell. Biochem. 101:695-711.
28. Yoshiba N, Yoshiba K, Hosoya A, Saito M, Yokoi T, Okiji T, Amizuka N, Ozawa H. 2007. Association of TIMP-2 with extracellular matrix exposed to mechanical stress and its co-distribution with periostin during mouse mandible development. Cell Tissue Res. 330:133-145.
29. Snider P, Hinton RB, Moreno-Rodriguez RA, Wang J, Rogers R, Lindsley A, Li F, Ingram DA, Menick D, Field L, Firulli AB, Molkentin JD, Markwald R, Conway SJ. 2008. Periostin is required for maturation and extracellular matrix stabilization of noncardiomyocyte lineages of the heart. Circ. Res. 102:752-760.
30. Shimazaki M, Nakamura K, Kii I, Kashima T, Amizuka N, Li M, Saito M, Fukuda K, Nishiyama T, Kitajima S, Saga Y, Fukayama M, Sata M, Kudo A. 2008. Periostin is essential for cardiac healing after acute myocardial infarction. J. Exp. Med. 205:295-303.
31. Sorocos K, Kostoulias X, Cullen-McEwen L, Hart AH, Bertram JF, Caruana G. 2011. Expression patterns and roles of periostin during kidney and ureter development. J. Urol. 186:1537-1544.
32. Rios H, Koushik SV, Wang H, Wang J, Zhou HM, Lindsley A, Rogers R, Chen Z, Maeda M, Kruzynska-Frejtag A, Feng JQ, Conway SJ. 2005. Periostin null mice exhibit dwarfism, incisor enamel defects, and an earlyonset periodontal disease-like phenotype. Mol. Cell. Biol. 25:11131-11144.
33. Pease ME, Cone FE, Gelman S, Son JL, Quigley HA. 2011. Calibration of the TonoLab tonometer in mice with spontaneous or experimental glaucoma. Invest. Ophthalmol. Vis. Sci. 52(2):858-864.
34. Filla MS, David G, Weinreb RN, Kaufman PL, Peters DM. 2004. Distribution of syndecans 1-4 within the anterior segment of the human eye: expression of a variant syndecan-3 and matrix-associated syndecan-2. Exp. Eye Res. 79:61-74.
35. Tamm ER, Russell P, Piatigorsky J. 1999. Development of characterization of a immortal and differentiated murine trabecular meshwork cell line. Invest. Ophthalmol. Vis. Sci. 40:1392-1403.
36. Begley CG, Yue BY, Hendricks RL. 1991. Murine trabecular meshwork cells in tissue culture. Curr. Eye Res. 10:1015-1030.
37. Park S, DiMaio TA, Scheef EA, Sorenson CM, Sheibani N. 2010. PECAM-1 regulates proangiogenic properties of endothelial cells through modulation of cell-cell and cell-matrix interactions. Am. J. Physiol. Cell Physiol. 299:C1468-C1484. doi:10.1152/ajpcell.00246.2010.
38. Ezzat MK, Howell KG, Bahler CK, Beito TG, Loewen N, Poeschla EM, Fautsch MP. 2008. Characterization of monoclonal antibodies against the glaucoma-associated protein myocilin. Exp. Eye Res. 87:376-384.
39. Su X, Sorenson CM, Sheibani N. 2003. Isolation and characterization of murine retinal endothelial cells. Mol. Vis. 9:171-178.
40. Kondo S, Scheef EA, Sheibani N, Sorenson CM. 2007. PECAM-1 isoform-specific regulation of kidney endothelial cell migration and capillary morphogenesis. Am. J. Physiol. Cell Physiol. 292:C2070-C2083. doi:10.1152/ajpcell.00489.2006.
41. Sheibani N, Morrison ME, Gurel Z, Park S, Sorenson CM. 2012. BIM deficiency differentially impacts the function of kidney endothelial and epithelial cells through modulation of their local microenvironment. Am. J. Physiol. Renal Physiol. 302:F809-F819. doi:10.1152/ajprenal.00498.2011.
42. Cone FE, Steinhart MR, Oglesby EN, Kalesnykas G, Pease ME, Quigley HA. 2012. The effects of anesthesia, mouse strain and age on intraocular pressure and an improved murine model of experimental glaucoma. Exp. Eye Res. 99:27-35.
43. Haddadin RI, Oh DJ, Kang MH, Villarreal G, Jr, Kang JH, Jin R, Gong H, Rhee DJ. 2012. Thrombospondin-1 (TSP1)-null and TSP2-null mice exhibit lower intraocular pressures. Invest. Ophthalmol. Vis. Sci. 53: 6708-6717.
44. Stamer WD. 2012. The cell and molecular biology of glaucoma: mechanisms in the conventional outflow pathway. Invest. Ophthalmol. Vis. Sci. 53:2470-2472.
45. Esterbauer H, Schaur RJ, Zollner H. 1991. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic. Biol. Med. 11:81-128.
46. Polansky JR, Wood IS, Maglio MT, Alvarado JA. 1984. Trabecular meshwork cell culture in glaucoma research: evaluation of biological activity and structural properties of human trabecular cells in vitro. Ophthalmology 91:580-595.
47. de Kater AW, Shahsafaei A, Epstein DL. 1992. Localization of smooth muscle and nonmuscle actin isoforms in the human aqueous outflow pathway. Invest. Ophthalmol. Vis. Sci. 33:424-429.
48. Wiederholt M. 1998. Direct involvement of trabecular meshwork in the regulation of aqueous humor outflow. Curr. Opin. Ophthalmol. 9:46-49.
49. Kuchtey J, Olson LM, Rinkoski T, Mackay EO, Iverson TM, Gelatt KN, Haines JL, Kuchtey RW. 2011. Mapping of the disease locus and identification of ADAMTS10 as a candidate gene in a canine model of primary open angle glaucoma. PLoS Genet. 7:e1001306. doi:10.1371/journal.pgen.1001306.
50. Du Y, Roh DS, Mann MM, Funderburgh ML, Funderburgh JL, Schuman JS. 2012. Multipotent stem cells from trabecular meshwork become phagocytic TM cells. Invest. Ophthalmol. Vis. Sci. 53:1566-1575.
51. Gonzalez P, Epstein DL, Luna C, Liton PB. 2006. Characterization of free-floating spheres from human trabecular meshwork (HTM) cell culture in vitro. Exp. Eye Res. 82:959-967.
52. Liton PB, Liu X, Stamer WD, Challa P, Epstein DL, Gonzalez P. 2005. Specific targeting of gene expression to a subset of human trabecular meshwork cells using the chitinase 3-like 1 promoter. Invest. Ophthalmol. Vis. Sci. 46:183-190.
53. Stamer WD, Peppel K, O'Donnell ME, Roberts BC, Wu F, Epstein DL. 2001. Expression of aquaporin-1 in human trabecular meshwork cells: role in resting cell volume. Invest. Ophthalmol. Vis. Sci. 42:1803-1811.
54. Baetz NW, Hoffman EA, Yool AJ, Stamer WD. 2009. Role of aquaporin-1 in trabecular meshwork cell homeostasis during mechanical strain. Exp. Eye Res. 89:95-100.
55. Stone EM, Fingert JH, Alward WL, Nguyen TD, Polansky JR, Sunden SL, Nishimura D, Clark AF, Nystuen A, Nichols BE, Mackey DA, Ritch R, Kalenak JW, Craven ER, Sheffield VC. 1997. Identification of a gene that causes primary open angle glaucoma. Science 275:668-670.
56. Resch ZT, Hann CR, Cook KA, Fautsch MP. 2010. Aqueous humor rapidly stimulates myocilin secretion from human trabecular meshwork cells. Exp. Eye Res. 91:901-908.
57. Wentz-Hunter K, Kubota R, Shen X, Yue BY. 2004. Extracellular myocilin affects activity of human trabecular meshwork cells. J. Cell. Physiol. 200:45-52.
58. Lo WR, Rowlette LL, Caballero M, Yang P, Hernandez MR, Borras T. 2003. Tissue differential microarray analysis of dexamethasone induction reveals potential mechanisms of steroid glaucoma. Invest. Ophthalmol. Vis. Sci. 44:473-485.
59. Wentz-Hunter K, Shen X, Yue BY. 2003. Distribution of myocilin, a glaucoma gene product, in human corneal fibroblasts. Mol. Vis. 9:308-314.
60. Brake PB, Zhang L, Jefcoate CR. 1998. Aryl hydrocarbon receptor regulation of cytochrome P4501B1 in rat mammary fibroblasts: evidence for transcriptional repression by glucocorticoids. Mol. Pharmacol. 54:825-833.
61. Filla MS, Liu X, Nguyen TD, Polansky JR, Brandt CR, Kaufman PL, Peters DM. 2002. In vitro localization of TIGR/MYOC in trabecular meshwork extracellular matrix and binding to fibronectin. Invest. Ophthalmol. Vis. Sci. 43:151-161.
62. Tektas OY, Lutjen-Drecoll E. 2009. Structural changes of the trabecular meshwork in different kinds of glaucoma. Exp. Eye Res. 88:769-775.
63. Chun YJ, Kim S, Kim D, Lee SK, Guengerich FP. 2001. A new selective and potent inhibitor of human cytochrome P450 1B1 and its application to antimutagenesis. Cancer Res. 61:8164-8170.
64. Tan JC, Peters DM, Kaufman PL. 2006. Recent developments in understanding the pathophysiology of elevated intraocular pressure. Curr. Opin. Ophthalmol. 17:168-174.
65. Tian B, Gabelt BT, Geiger B, Kaufman PL. 2009. The role of the actomyosin system in regulating trabecular fluid outflow. Exp. Eye Res. 88: 713-717.
66. Tian B, Geiger B, Epstein DL, Kaufman PL. 2000. Cytoskeletal involvement in the regulation of aqueous humor outflow. Invest. Ophthalmol. Vis. Sci. 41:619-623.
67. Lutjen-Drecoll E, Gabelt BT, Tian B, Kaufman PL. 2001. Outflow of aqueous humor. J. Glaucoma 10(Suppl.1):S42-S44.
68. Savinova OV, Sugiyama F, Martin JE, Tomarev SI, Paigen BJ, Smith RS, John SW. 2001. Intraocular pressure in genetically distinct mice: an update and strain survey. BMC Genet. 2:12. doi:10.1186/1471-2156-2-12.
69. Chang B, Smith RS, Peters M, Savinova OV, Hawes NL, Zabaleta A, Nusinowitz S, Martin JE, Davisson ML, Cepko CL, Hogan BL, John SW. 2001. Haploinsufficient Bmp4 ocular phenotypes include anterior segment dysgenesis with elevated intraocular pressure. BMC Genet. 2:18. doi:10.1186/1471-2156-2-18.
70. Alper MG. 1963. Contusion angle deformity and glaucoma. Gonioscopic observations and clinical course. Arch. Ophthalmol. 69:455-467.
71. Zhang Y, Davidson BR, Stamer WD, Barton JK, Marmorstein LY, Marmorstein AD. 2009. Enhanced inflow and outflow rates despite lower IOP in bestrophin-2-deficient mice. Invest. Ophthalmol. Vis. Sci. 50:765-770.
72. Haddadin RI, Oh DJ, Kang MH, Filippopoulos T, Gupta M, Hart L, Sage EH, Rhee DJ. 2009. SPARC-null mice exhibit lower intraocular pressures. Invest. Ophthalmol. Vis. Sci. 50:3771-3777.
73. Smith RS, Zabaleta A, Kume T, Savinova OV, Kidson SH, Martin JE, Nishimura DY, Alward WL, Hogan BL, John SW. 2000. Haploinsufficiency of the transcription factors FOXC1 and FOXC2 results in aberrant ocular development. Hum. Mol. Genet. 9:1021-1032.
74. Smith R, John S, Nishina P, Sundberg J. 2001. Systematic evaluation of the mouse eye: anatomy, pathology and biomethods. CRC Press, Bocan Raton, FL.
75. Slominski A, Tobin DJ, Shibahara S, Wortsman J. 2004. Melanin pigmentation in mammalian skin and its hormonal regulation. Physiol. Rev. 84:1155-1228.
76. Ilia M, Jeffery G. 1999. Retinal mitosis is regulated by dopa, a melanin precursor that may influence the time at which cells exit the cell cycle: analysis of patterns of cell production in pigmented and albino retinae. J. Comp. Neurol. 405:394-405.
77. Thomas SA, Matsumoto AM, Palmiter RD. 1995. Noradrenaline is essential for mouse fetal development. Nature 374:643-646.
78. Rockwood JM, Maxwell GD. 1996. An analysis of the effects of retinoic acid and other retinoids on the development of adrenergic cells from the avian neural crest. Exp. Cell Res. 223:250-258.
79. Clark AF. 2012. The cell and molecular biology of glaucoma: biomechanical factors in glaucoma. Invest. Ophthalmol. Vis. Sci. 53:2473-2475.
80. Zhou L, Li Y, Yue BY. 1999. Oxidative stress affects cytoskeletal structure and cell-matrix interactions in cells from an ocular tissue: the trabecular meshwork. J. Cell. Physiol. 180:182-189.